Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DRUG COMPOSITION FOR PARENTERAL ADMINISTRATION
Document Type and Number:
WIPO Patent Application WO/2018/003857
Kind Code:
A1
Abstract:
Provided is a curcumine preparation which is highly water soluble, is capable of maintaining a sufficiently high blood concentration of free curcumine and capable of effectively obtaining the pharmacological effect of curcumine by parenteral administration, and which is highly safe. The pharmaceutical composition for parenteral administration comprises a water-soluble substance conjugate of curcumine as the active ingredient.

Inventors:
KAKEYA HIDEAKI (JP)
KANAI MASASHI (JP)
TAKAHASHI NOBUAKI (JP)
HASHIMOTO TADASHI (JP)
IMAIZUMI ATSUSHI (JP)
OZAWA HIROMI (JP)
Application Number:
PCT/JP2017/023753
Publication Date:
January 04, 2018
Filing Date:
June 28, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
THERABIOPHARMA INC (JP)
UNIV KYOTO (JP)
International Classes:
A61K31/7028; A61K31/12; A61K31/185; A61K31/223; A61K38/00; A61P3/06; A61P9/00; A61P25/28; A61P29/00; A61P35/00; A61P37/08
Foreign References:
US20100316631A12010-12-16
JP2015054846A2015-03-23
JP2007319030A2007-12-13
JP2009529506A2009-08-20
Other References:
THANGAVEL, A ET AL.: "Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer", J. CONTROLLED RELEASE, vol. 209, 22 April 2015 (2015-04-22), pages 110 - 119, XP029173931
SAHU, A ET AL.: "Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells", ACTA BIOMATERIALIA, vol. 4, no. 6, 11 May 2008 (2008-05-11), pages 1752 - 1761, XP025535837
See also references of EP 3479828A4
Attorney, Agent or Firm:
THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)
Download PDF: